Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 417 | 210 | 386 | 608 | 573 |
| Operating Income | -417 | -210 | -386 | -608 | -573 |
| Interest Expense | 178 | 114 | 157 | 99 | 163 |
| Other Income | 245 | -423 | -268 | 92 | 118 |
| Pre-tax Income | -351 | -747 | -812 | -615 | -617 |
| Income Tax | N/A | 1 | -2 | -129 | N/A |
| Net Income Continuous | -351 | -748 | -810 | -485 | -617 |
| Net Income | $-351 | $-748 | $-810 | $-485 | $-617 |
| EPS Basic Total Ops | -0.04 | 1.28 | -0.42 | -0.53 | -2.13 |
| EPS Basic Continuous Ops | -0.03 | 0.70 | -0.42 | -0.51 | -1.30 |
| EPS Diluted Total Ops | -0.04 | 1.28 | -0.42 | -0.53 | -2.13 |
| EPS Diluted Continuous Ops | -0.03 | 0.70 | -0.42 | -0.51 | -1.30 |
| EBITDA(a) | $-417 | $-209 | $-386 | $-608 | $-572 |